| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $471.8M | +32.7% |
| Cost of Revenue | $147.5M | +27.4% |
| Gross Profit | $324.3M | +35.3% |
| R&D Expense | $119.9M | +23.2% |
| SG&A Expense | $102.0M | +14.9% |
| Operating Income | -$144.7M | +2.3% |
| Pre-tax Income | -$128.5M | +8.3% |
| Income Tax | $2.0M | +235.7% |
| Net Income | -$129.2M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.2M | -0.5% |
| Accounts Receivable | $92.3M | +17.8% |
| Current Assets | $601.1M | +3.1% |
| Total Assets | $810.9M | +15.0% |
| Current Liabilities | $289.4M | +33.2% |
| Total Liabilities | $366.5M | +41.7% |
| Stockholders' Equity | $444.2M | -0.2% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.8M | +130.7% |
| Capital Expenditures | $9.8M | -36.8% |
| Investing Cash Flow | -$20.0M | +95.0% |
| Financing Cash Flow | $13.1M | +15.7% |
| Free Cash Flow | -$2.9M | +92.3% |
| +7.1% |
| EPS (Basic) | -$1.32 | +10.2% |
| EPS (Diluted) | -$1.32 | +10.2% |